CSPC Financial Statements From 2010 to 2025
CSPC Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CSPC Pharmaceutical's valuation are provided below:CSPC Pharmaceutical Group does not now have any fundamental signals for analysis.
This module can also supplement various CSPC Pharmaceutical Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in banks.
Check CSPC Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSPC Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . CSPC financial statements analysis is a perfect complement when working with CSPC Pharmaceutical Valuation or Volatility modules.
CSPC |
CSPC Pharmaceutical Group Company Operating Margin Analysis
CSPC Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CSPC Pharmaceutical Operating Margin | 0.22 % |
Most of CSPC Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC Pharmaceutical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, CSPC Pharmaceutical Group has an Operating Margin of 0.2214%. This is 100.63% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 104.02% lower than that of the firm.
CSPC Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSPC Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CSPC Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSPC Pharmaceutical competition to find correlations between indicators driving CSPC Pharmaceutical's intrinsic value. More Info.CSPC Pharmaceutical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSPC Pharmaceutical Group is roughly 1.77 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CSPC Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CSPC Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About CSPC Pharmaceutical Financial Statements
CSPC Pharmaceutical investors use historical fundamental indicators, such as CSPC Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CSPC Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CSPC Pink Sheet Analysis
When running CSPC Pharmaceutical's price analysis, check to measure CSPC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSPC Pharmaceutical is operating at the current time. Most of CSPC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CSPC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSPC Pharmaceutical's price. Additionally, you may evaluate how the addition of CSPC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.